Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Therapy
Single-agent trastuzumab show promise for breast cancer
April 28th, 2005
Single-agent trastuzumab shows promise in metastatic breast cancer. According to W.J. Kostler and coworkers, Medical University of Vienna, "Trastuzumab has shown significant single-agent activity in patients with Her-2/neu overexpressing metastatic breast cancer, and increased response rates, progression-free, and overall survival when added to standard chemotherapy. "Despite higher response rates, the combination with chemotherapy has higher toxicity, and it remains unknown whether single-agent trastuzumab is equally effective as the combined treatment in terms of progression-free and overall survival." "We therefore carried out...
Source: Women's Health Weekly (2005-04-28)
|
